---
figid: PMC3496878__WJG-18-6005-g001
figtitle: Signal transduction in solid cancer cells including hepatocellular carcinoma
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3496878
filename: WJG-18-6005-g001.jpg
figlink: /pmc/articles/PMC3496878/figure/F1/
number: F1
caption: 'Signal transduction in solid cancer cells including hepatocellular carcinoma.
  Some of the genes known to be functionally altered are highlighted in red. These
  signaling pathways, including growth factor pathway, Wnt pathway, Hedgehog pathway,
  Akt/mammalian target of rapamycin (mTOR) pathway, and Jak/Stat pathway, can be a
  molecular targets for treatment of hepatocellular carcinoma. (Cited and modified
  from Hanahan et al[] with permission.) EGFR: Epidermal growth factor receptor; TGF:
  Transforming growth factor; IGF: Insulin-like growth factor; MAPK: Mitogen-activated
  protein kinase; PI3K: Phosphoinositide 3-kinase; ERK: Extracellular signaling-regulated
  kinase; NF-κB: Nuclear factor-kappa B; IL: Interleukin.'
papertitle: Signaling pathway/molecular targets and new targeted agents under development
  in hepatocellular carcinoma.
reftext: Masatoshi Kudo. World J Gastroenterol. 2012 Nov 14;18(42):6005-6017.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9426895
figid_alias: PMC3496878__F1
figtype: Figure
redirect_from: /figures/PMC3496878__F1
ndex: 22b4d92f-df01-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3496878__WJG-18-6005-g001.html
  '@type': Dataset
  description: 'Signal transduction in solid cancer cells including hepatocellular
    carcinoma. Some of the genes known to be functionally altered are highlighted
    in red. These signaling pathways, including growth factor pathway, Wnt pathway,
    Hedgehog pathway, Akt/mammalian target of rapamycin (mTOR) pathway, and Jak/Stat
    pathway, can be a molecular targets for treatment of hepatocellular carcinoma.
    (Cited and modified from Hanahan et al[] with permission.) EGFR: Epidermal growth
    factor receptor; TGF: Transforming growth factor; IGF: Insulin-like growth factor;
    MAPK: Mitogen-activated protein kinase; PI3K: Phosphoinositide 3-kinase; ERK:
    Extracellular signaling-regulated kinase; NF-κB: Nuclear factor-kappa B; IL: Interleukin.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - TGFB1
  - TGFB2
  - TGFB3
  - HNF4A
  - APC
  - PROC
  - GATA4
  - FEZF2
  - CDKN2A
  - H3P10
  - CDC42
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - DHH
  - IHH
  - SHH
  - CDKN2B
  - CECR7
  - CYC1
  - CCNI
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - PTK2
  - CSE1L
  - CTNND1
  - BCAR1
  - TMX2-CTNND1
  - CRK
  - SRC
  - FGR
  - FYN
  - YES1
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - PYM1
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - NF1
  - IGF1
  - JUN
  - JUNB
  - JUND
  - MKKS
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MOS
  - MOCOS
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - GRB2
  - KRAS
  - HRAS
  - NRAS
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - EGFR
  - MAP3K1
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - MET
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - BAS
  - STAT5A
  - STAT5B
  - STAT3
  - SOAT1
  - STAT1
  - STAT2
  - STAT4
  - STAT6
  - MTOR
  - AKT2
  - AKT3
  - DEFB1
  - PTEN
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - FAP
  - CEL
  - GLMN
  - FAS
  - FASN
  - BAD
  - BID
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - FASLG
  - BCL2L11
  - SAT1
  - IL3
  - bombesin
  - estrogen
  - Autoimmune lymphoproliferative syndrome
  - Cancer
  - Lung cancer
---
